Tamara T Lah
Overview
Explore the profile of Tamara T Lah including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
59
Citations
1391
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bubik A, Frangez R, Zuzek M, Gutierrez-Aguirre I, Lah T, Sedmak B
Toxins (Basel)
. 2024 Sep;
16(9).
PMID: 39330832
The systemic toxicity of cyclic peptides produced by cyanobacteria (CCPs) is not yet completely understood. Apart from the most known damages to the liver and kidneys, symptoms of their neurotoxicity...
2.
Lah T, Majc B, Novak M, Susnik A, Breznik B, Porcnik A, et al.
Cancers (Basel)
. 2022 Dec;
14(23).
PMID: 36497400
Glioblastoma (GBM) is one of the most aggressive cancers, comprising 60-70% of all gliomas. The large G-protein-coupled receptor family includes cannabinoid receptors CB1, CB2, GPR55, and non-specific ion receptor protein...
3.
Majc B, Novak M, Lah T, Krizaj I
Front Oncol
. 2022 Sep;
12:965882.
PMID: 36119523
Venoms are complex mixtures of different molecules and ions. Among them, bioactive peptides have been found to affect cancer hallmarks, such as cell proliferation, cell invasion, cell migration, and can...
4.
Lah T, Novak M, Pena Almidon M, Marinelli O, Baskovic B, Majc B, et al.
Cells
. 2021 Feb;
10(2).
PMID: 33562819
Glioblastoma is the most aggressive cancer among primary brain tumours. As with other cancers, the incidence of glioblastoma is increasing; despite modern therapies, the overall mean survival of patients post-diagnosis...
5.
Majc B, Sever T, Zaric M, Breznik B, Turk B, Lah T
Biochim Biophys Acta Mol Cell Res
. 2020 Jun;
1867(10):118782.
PMID: 32554164
Epithelial-to-mesenchymal transition (EMT) is an essential molecular and cellular process that is part of normal embryogenesis and wound healing, and also has a ubiquitous role in various types of carcinoma...
6.
Kranjc M, Novak M, Pestell R, Lah T
Radiol Oncol
. 2019 Nov;
53(4):397-406.
PMID: 31747383
Background Glioblastoma is the most frequent and aggressive brain tumour in humans with median survival from 12 to 15 months after the diagnosis. This is mostly due to therapy resistant...
7.
Lah T, Novak M, Breznik B
Semin Cancer Biol
. 2019 Oct;
60:262-273.
PMID: 31654711
Brain, the major organ of the central nervous system controls and processes most of body activities. Therefore, the most aggressive brain tumor - glioblastoma and metastases from other organs to...
8.
Oliveira M, Breznik B, Pillat M, Pereira R, Ulrich H, Lah T
Cancer Microenviron
. 2019 Aug;
12(2-3):77-94.
PMID: 31420805
Tumour progression involves interactions among various cancer cell clones, including the cancer stem cell subpopulation and exogenous cellular components, termed cancer stromal cells. The latter include a plethora of tumour...
9.
Breznik B, Mitrovic A, Lah T, Kos J
Biochimie
. 2019 May;
166:233-250.
PMID: 31071357
Cystatins are endogenous and reversible inhibitors of cysteine peptidases that are important players in cancer progression. Besides their primary role as regulators of cysteine peptidase activity, cystatins are involved in...
10.
Breznik B, Limback C, Porcnik A, Blejec A, Koprivnikar Krajnc M, Bosnjak R, et al.
Radiol Oncol
. 2018 Oct;
52(4):433-442.
PMID: 30367810
Background Glioblastoma is a highly aggressive central nervous system neoplasm characterized by extensive infiltration of malignant cells into brain parenchyma, thus preventing complete tumor eradication. Cysteine cathepsins B, S, L...